nfr-logonfr-logo
PROJECT BANK
Bytt til Norsk språk
Statistics
Projects

0 projects

Date from new to old

FRIMEDBIO-Fri prosjektstøtte for medisin, helse og biologi

New diagnostic markers and targets for therapeutic intervention in B-cell lymphoma

Lymfekreft er den vanligste formen for kreft i blod- og lymfesystemet. Sykdommen kan deles inn i mange undergrupper som har ulik prognose og som krever ulik behandling. Diffust storcellet B-celle lymfom (DLBCL) er den mest vanlige formen for aggressiv lymfekreft, mens follikulært lymfom (FL) er d...

Awarded: NOK 8.3 mill.

Project Period: 2014-2018

Location: Oslo

FRIMEDBIO-Fri prosjektstøtte for medisin, helse og biologi

Molecular characterization and functional studies of human B cell lymphoma

Malignant lymphomas represent a heterogeneous group of diseases with variable clinical course. Our group aims at identifying genes/signalling pathways with prognostic, diagnostic or therapeutic potential in B cell lymphomas. We are one of 7 groups that co nstitute the newly established Centre for...

Awarded: NOK 3.2 mill.

Project Period: 2008-2013

Location: Oslo

FRIMEDBIO-Fri prosjektstøtte for medisin, helse og biologi

Studies of growth control and gene expression in normal and neoplastic B-lymphoid cells

Malignant lymphomas represent a heterogeneous group of diseases with variable clinical course. The complex biology and the variety of genetic and epigenetic factors involved in the pathogenesis make lymphomas a challenging disease for translational resear ch. There a clear need for the developmen...

Awarded: NOK 2.3 mill.

Project Period: 2006-2012

Location: Oslo

MILJO-Miljøstøtte

Strategies for molecular characterisation of human B-cell lymphomas. Diagnostic and therapeutical potential

...

Awarded: NOK 3.0 mill.

Project Period: 2003-2007

Location: Oslo

1